Stockholders’ Equity (Details) - Schedule of Stock-Based Compensation Expense for Restricted Stock - Restricted Stock [Member] - USD ($) |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2023 |
Jun. 30, 2022 |
Jun. 30, 2023 |
Jun. 30, 2022 |
|
| Stockholders’ Equity (Details) - Schedule of Stock-Based Compensation Expense for Restricted Stock [Line Items] | ||||
| General and administrative | $ 855,468 | $ 656,142 | $ 1,473,307 | $ 1,302,994 |
| Sales and marketing | 9,498 | 5,428 | 18,893 | 5,428 |
| Research and development | 463,151 | 362,198 | 794,344 | 711,099 |
| Total stock-based expense related to restricted stock units | $ 1,328,117 | $ 1,023,768 | $ 2,286,544 | $ 2,019,521 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of other research and development expense. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of selling and marketing expense classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of noncash expense for share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|